Denali Capital Acquisition Corp. extends combination deadline to Jan 11, 2025; deposits $15,064

Semnur Pharmaceuticals, Inc.

Deposited $15,063.74 into trust account to extend deadline from Dec 11, 2024 to Jan 11, 2025.
Extension funded via convertible promissory note from Scilex Holding Company (Nasdaq: SCLX) for up to $180,000.
Note bears no interest, repayable upon business combination or liquidation; convertible at $10.00/share into Class A ordinary shares.
Remaining $104,708.30 principal available for future monthly extensions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.